What is ESAB's health score?

ESAB Corp (ESAB) has a TradeApes health score of 46 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ESAB's estimated fair value?

Based on our 5-year discounted cash flow model, ESAB Corp's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ESAB undervalued or overvalued?

Our model currently rates ESAB as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ESAB... Refresh in a moment for the full analysis.

ESAB Corp (ESAB)

Technology Overvalued low mixed

$88.31

Updated: 2026-06-04

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

40 Weak

Relative Value

20 Stressed

Capital Allocation

45 Mixed

Risk

70 Healthy

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.